- Home
- / Karuna Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Karuna Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$329.8
2024-03-18
Market Capitalization
$12.6 B
2024-03-18
Revenue
$654 K
FY, 2023
CreditSafe Score
?
Score changed on Jun 03, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | 37.0M | 10.6M | 654.0K | ||||
| General and administrative expense | 1.2M | 3.0M | 20.9M | 28.4M | 52.6M | 76.1M | 131.3M |
| Operating expense total | 4.8M | 14.5M | 45.4M | 71.8M | 300.3M | 495.4M | |
| EBIT | (4.8M) | (14.5M) | (45.4M) | (71.8M) | (143.9M) | (289.7M) | (494.8M) |
| EBIT margin, % | -2723.3% | -75654.0% | |||||
| Investment income | 2.5M | 3.3M | 502.0K | 14.2M | |||
| Interest income | 25.0K | ||||||
| Interest expense | 555.0K | 407.0K | 11.0K | 61.2M | |||
| Pre tax profit | (6.0M) | (17.5M) | (44.0M) | (68.5M) | (143.8M) | (274.9M) | (433.0M) |
| Income tax expense | 43.0K | 6.0K | 1.4M | 700.0K | |||
| Net Income | (6.0M) | (17.5M) | (44.0M) | (68.6M) | (143.8M) | (276.3M) | (433.7M) |
| EPS | (8.7) | (11.7) |